Meituan
HKEX:3690
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
62.55
213.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Meituan
Revenue
|
305.7B
CNY
|
Cost of Revenue
|
-194.1B
CNY
|
Gross Profit
|
111.6B
CNY
|
Operating Expenses
|
-88.2B
CNY
|
Operating Income
|
23.4B
CNY
|
Other Expenses
|
-860.3m
CNY
|
Net Income
|
22.5B
CNY
|
Income Statement
Meituan
Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||
Revenue |
46 497
N/A
|
65 573
+41%
|
65 227
-1%
|
73 126
+12%
|
80 756
+10%
|
89 174
+10%
|
97 529
+9%
|
95 109
-2%
|
97 128
+2%
|
105 035
+8%
|
114 795
+9%
|
135 057
+18%
|
154 094
+14%
|
167 522
+9%
|
179 128
+7%
|
188 380
+5%
|
195 559
+4%
|
209 349
+7%
|
219 955
+5%
|
232 303
+6%
|
249 330
+7%
|
263 178
+6%
|
276 745
+5%
|
291 404
+5%
|
305 690
+5%
|
|
Gross Profit | ||||||||||||||||||||||||||
Cost of Revenue |
(33 660)
|
(48 165)
|
(50 122)
|
(56 163)
|
(58 694)
|
(62 090)
|
(65 208)
|
(62 661)
|
(64 045)
|
(70 722)
|
(80 744)
|
(99 003)
|
(114 102)
|
(127 575)
|
(136 654)
|
(142 366)
|
(146 484)
|
(152 547)
|
(158 202)
|
(161 474)
|
(168 677)
|
(174 048)
|
(179 554)
|
(188 334)
|
(194 128)
|
|
Gross Profit |
12 838
N/A
|
17 409
+36%
|
15 105
-13%
|
16 962
+12%
|
22 062
+30%
|
27 083
+23%
|
32 320
+19%
|
32 447
+0%
|
33 081
+2%
|
34 312
+4%
|
34 050
-1%
|
36 054
+6%
|
39 992
+11%
|
39 947
0%
|
42 474
+6%
|
46 014
+8%
|
49 075
+7%
|
56 802
+16%
|
61 753
+9%
|
70 829
+15%
|
80 653
+14%
|
89 130
+11%
|
97 191
+9%
|
103 070
+6%
|
111 562
+8%
|
|
Operating Income | ||||||||||||||||||||||||||
Operating Expenses |
(21 023)
|
(28 704)
|
(28 582)
|
(29 833)
|
(29 791)
|
(30 308)
|
(30 974)
|
(28 763)
|
(29 099)
|
(30 650)
|
(36 095)
|
(40 085)
|
(49 210)
|
(56 645)
|
(64 681)
|
(66 042)
|
(65 941)
|
(65 884)
|
(68 102)
|
(68 876)
|
(73 745)
|
(79 993)
|
(87 058)
|
(86 529)
|
(88 171)
|
|
Selling, General & Administrative |
(16 363)
|
(22 307)
|
(20 703)
|
(22 970)
|
(23 293)
|
(24 020)
|
(21 444)
|
(22 709)
|
(22 852)
|
(23 432)
|
(24 984)
|
(31 151)
|
(38 723)
|
(45 247)
|
(47 370)
|
(51 770)
|
(50 358)
|
(49 975)
|
(47 495)
|
(50 528)
|
(55 730)
|
(61 781)
|
(65 944)
|
(71 747)
|
(72 583)
|
|
Research & Development |
(5 263)
|
(7 266)
|
(7 031)
|
(7 725)
|
(8 053)
|
(8 187)
|
(8 208)
|
(8 705)
|
(9 050)
|
(9 883)
|
(10 584)
|
(12 073)
|
(13 597)
|
(15 343)
|
(16 239)
|
(18 078)
|
(19 381)
|
(20 079)
|
(20 108)
|
(20 908)
|
(21 111)
|
(21 018)
|
(20 578)
|
(21 153)
|
(21 086)
|
|
Depreciation & Amortization |
0
|
0
|
(1 041)
|
0
|
0
|
0
|
(1 952)
|
0
|
0
|
0
|
(1 801)
|
0
|
0
|
0
|
(2 362)
|
0
|
0
|
0
|
(2 654)
|
0
|
0
|
0
|
(2 668)
|
0
|
0
|
|
Other Operating Expenses |
603
|
869
|
194
|
863
|
1 556
|
1 901
|
630
|
2 651
|
2 803
|
2 664
|
1 274
|
3 139
|
3 110
|
3 946
|
1 290
|
3 808
|
3 799
|
4 170
|
2 154
|
2 560
|
3 098
|
2 808
|
2 132
|
6 373
|
5 497
|
|
Operating Income |
(8 186)
N/A
|
(11 296)
-38%
|
(13 477)
-19%
|
(12 871)
+4%
|
(7 729)
+40%
|
(3 224)
+58%
|
1 347
N/A
|
3 685
+174%
|
3 983
+8%
|
3 663
-8%
|
(2 045)
N/A
|
(4 031)
-97%
|
(9 218)
-129%
|
(16 699)
-81%
|
(22 207)
-33%
|
(20 028)
+10%
|
(16 866)
+16%
|
(9 082)
+46%
|
(6 349)
+30%
|
1 954
N/A
|
6 909
+254%
|
9 138
+32%
|
10 133
+11%
|
16 541
+63%
|
23 390
+41%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||
Interest Income Expense |
1 810
|
1 524
|
2 618
|
1 707
|
593
|
1 057
|
1 944
|
(506)
|
199
|
5 827
|
6 121
|
5 503
|
5 185
|
(637)
|
1 677
|
(552)
|
(1 524)
|
(1 394)
|
(106)
|
769
|
1 779
|
1 978
|
5 026
|
651
|
842
|
|
Non-Reccuring Items |
0
|
0
|
(6)
|
0
|
(139)
|
(251)
|
(514)
|
(821)
|
(728)
|
(746)
|
386
|
(196)
|
(254)
|
(3 703)
|
(2 986)
|
(3 888)
|
(3 834)
|
(539)
|
(254)
|
(355)
|
(500)
|
(492)
|
(1 135)
|
(1 055)
|
(1 136)
|
|
Total Other Income |
(28 813)
|
(108 569)
|
(104 626)
|
(84 393)
|
(79 756)
|
0
|
(15)
|
0
|
0
|
0
|
(25)
|
0
|
0
|
0
|
(50)
|
0
|
0
|
0
|
(46)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
|
Pre-Tax Income |
(35 189)
N/A
|
(118 342)
-236%
|
(115 491)
+2%
|
(95 557)
+17%
|
(87 031)
+9%
|
(2 417)
+97%
|
2 762
N/A
|
2 358
-15%
|
3 453
+46%
|
8 743
+153%
|
4 438
-49%
|
1 276
-71%
|
(4 286)
N/A
|
(21 037)
-391%
|
(23 566)
-12%
|
(24 467)
-4%
|
(22 223)
+9%
|
(11 014)
+50%
|
(6 756)
+39%
|
2 370
N/A
|
8 190
+246%
|
10 624
+30%
|
14 022
+32%
|
16 137
+15%
|
23 095
+43%
|
|
Net Income | ||||||||||||||||||||||||||
Tax Provision |
(142)
|
(286)
|
(2)
|
(303)
|
(237)
|
(220)
|
(526)
|
(268)
|
(29)
|
(332)
|
270
|
165
|
160
|
596
|
30
|
74
|
71
|
73
|
70
|
7
|
(8)
|
(66)
|
(165)
|
(269)
|
(563)
|
|
Income from Continuing Operations |
(35 332)
|
(118 629)
|
(115 493)
|
(95 860)
|
(87 268)
|
(2 638)
|
2 236
|
2 090
|
3 424
|
8 412
|
4 708
|
1 441
|
(4 125)
|
(20 440)
|
(23 536)
|
(24 392)
|
(22 152)
|
(10 941)
|
(6 685)
|
2 375
|
8 180
|
10 556
|
13 857
|
15 868
|
22 531
|
|
Income to Minority Interest |
63
|
65
|
16
|
4
|
(5)
|
(5)
|
3
|
3
|
1
|
0
|
1
|
0
|
(1)
|
(2)
|
(2)
|
(1)
|
0
|
0
|
(1)
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
|
Net Income (Common) |
(35 270)
N/A
|
(118 565)
-236%
|
(115 477)
+3%
|
(95 858)
+17%
|
(87 275)
+9%
|
(2 645)
+97%
|
2 239
N/A
|
2 092
-7%
|
3 425
+64%
|
8 412
+146%
|
4 708
-44%
|
1 440
-69%
|
(4 127)
N/A
|
(20 444)
-395%
|
(23 538)
-15%
|
(24 393)
-4%
|
(22 153)
+9%
|
(10 942)
+51%
|
(6 686)
+39%
|
2 373
N/A
|
8 178
+245%
|
10 555
+29%
|
13 856
+31%
|
15 866
+15%
|
22 530
+42%
|
|
EPS (Diluted) |
-22.74
N/A
|
-76.41
-236%
|
-42.4
+45%
|
-35.19
+17%
|
-9.97
+72%
|
-0.46
+95%
|
0.38
N/A
|
0.36
-5%
|
0.57
+58%
|
1.43
+151%
|
0.81
-43%
|
0.24
-70%
|
-0.69
N/A
|
-3.44
-399%
|
-3.9
-13%
|
-3.94
-1%
|
-3.6
+9%
|
-1.78
+51%
|
-1.09
+39%
|
0.4
N/A
|
1.27
+218%
|
1.69
+33%
|
2.19
+30%
|
2.51
+15%
|
3.62
+44%
|